UA96488C2 - СРЕДСТВО С СВОЙСТВОМ ФОРМИРОВАНИЯ КЛЕТОЧНОГО ИММУНИТЕТА ПРОТИВ MYCOBACTERIUM TUBERCULOSIS H37 Rv, СПОСОБ ЕГО ПОЛУЧЕНИЯ (ВАРИАНТЫ), РЕКОМБИНАНТНЫЙ ШТАММ И СРЕДСТВО ДЛЯ ДИАГНОСТИКИ ТУБЕРКУЛЕЗА - Google Patents

СРЕДСТВО С СВОЙСТВОМ ФОРМИРОВАНИЯ КЛЕТОЧНОГО ИММУНИТЕТА ПРОТИВ MYCOBACTERIUM TUBERCULOSIS H37 Rv, СПОСОБ ЕГО ПОЛУЧЕНИЯ (ВАРИАНТЫ), РЕКОМБИНАНТНЫЙ ШТАММ И СРЕДСТВО ДЛЯ ДИАГНОСТИКИ ТУБЕРКУЛЕЗА

Info

Publication number
UA96488C2
UA96488C2 UAA200912563A UAA200912563A UA96488C2 UA 96488 C2 UA96488 C2 UA 96488C2 UA A200912563 A UAA200912563 A UA A200912563A UA A200912563 A UAA200912563 A UA A200912563A UA 96488 C2 UA96488 C2 UA 96488C2
Authority
UA
Ukraine
Prior art keywords
tuberculosis
agent
tuberculous
immunity against
cellular immunity
Prior art date
Application number
UAA200912563A
Other languages
English (en)
Ukrainian (uk)
Inventor
Николай Николаевич Кисличкин
Original Assignee
Общество С Ограниченной Ответственностью "Биотэк"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Общество С Ограниченной Ответственностью "Биотэк" filed Critical Общество С Ограниченной Ответственностью "Биотэк"
Publication of UA96488C2 publication Critical patent/UA96488C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/5695—Mycobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Public Health (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
UAA200912563A 2007-05-10 2008-04-29 СРЕДСТВО С СВОЙСТВОМ ФОРМИРОВАНИЯ КЛЕТОЧНОГО ИММУНИТЕТА ПРОТИВ MYCOBACTERIUM TUBERCULOSIS H37 Rv, СПОСОБ ЕГО ПОЛУЧЕНИЯ (ВАРИАНТЫ), РЕКОМБИНАНТНЫЙ ШТАММ И СРЕДСТВО ДЛЯ ДИАГНОСТИКИ ТУБЕРКУЛЕЗА UA96488C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2007117342/13A RU2341288C1 (ru) 2007-05-10 2007-05-10 СРЕДСТВО, ОБЛАДАЮЩЕЕ СВОЙСТВОМ ФОРМИРОВАТЬ КЛЕТОЧНЫЙ ИММУНИТЕТ ПРОТИВ MYCOBACTERIUM TUBERCULOSIS H37 Rv, СПОСОБ ПОЛУЧЕНИЯ ЕГО (ВАРИАНТЫ), РЕКОМБИНАНТНЫЙ ШТАММ И СРЕДСТВО ДЛЯ ДИАГНОСТИКИ ТУБЕРКУЛЕЗА

Publications (1)

Publication Number Publication Date
UA96488C2 true UA96488C2 (ru) 2011-11-10

Family

ID=40002430

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200912563A UA96488C2 (ru) 2007-05-10 2008-04-29 СРЕДСТВО С СВОЙСТВОМ ФОРМИРОВАНИЯ КЛЕТОЧНОГО ИММУНИТЕТА ПРОТИВ MYCOBACTERIUM TUBERCULOSIS H37 Rv, СПОСОБ ЕГО ПОЛУЧЕНИЯ (ВАРИАНТЫ), РЕКОМБИНАНТНЫЙ ШТАММ И СРЕДСТВО ДЛЯ ДИАГНОСТИКИ ТУБЕРКУЛЕЗА

Country Status (6)

Country Link
EP (1) EP2156844A4 (ru)
CN (1) CN101861166A (ru)
EA (1) EA014065B1 (ru)
RU (1) RU2341288C1 (ru)
UA (1) UA96488C2 (ru)
WO (1) WO2008140353A1 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101603017B (zh) * 2009-06-05 2012-07-04 天津科技大学 一种约氏不动杆菌lp28以及利用该菌制备低温碱性脂肪酶的方法
CN103675293B (zh) * 2013-11-25 2015-10-28 广东体必康生物科技有限公司 Rv3872、Rv0164和/或Rv1926c蛋白在制备诊断活动性肺结核的产品中的用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB860305A (en) * 1958-06-12 1961-02-01 Yamamura Yuichi Tuberculin active peptide
US6183957B1 (en) * 1998-04-16 2001-02-06 Institut Pasteur Method for isolating a polynucleotide of interest from the genome of a mycobacterium using a BAC-based DNA library application to the detection of mycobacteria
RU2237090C1 (ru) * 2003-04-24 2004-09-27 Институт химической биологии и фундаментальной медицины СО РАН Способ генетического типирования штаммов микобактерий туберкулезного комплекса
RU2262351C1 (ru) * 2003-12-26 2005-10-20 ООО "Фирма "БиоМедИнвест" Вакцинная композиция для профилактики и лечения туберкулезной инфекции и генетические конструкции для получения действующих компонентов этой композиции
CN1869239A (zh) * 2006-06-01 2006-11-29 南京农业大学 一种融合蛋白的酵母表达载体及其基因工程产品

Also Published As

Publication number Publication date
EA200901503A1 (ru) 2010-04-30
WO2008140353A1 (ru) 2008-11-20
WO2008140353A8 (ru) 2009-07-16
EA014065B1 (ru) 2010-08-30
RU2341288C1 (ru) 2008-12-20
CN101861166A (zh) 2010-10-13
EP2156844A4 (en) 2010-12-29
EP2156844A1 (en) 2010-02-24

Similar Documents

Publication Publication Date Title
Chen et al. Linking exoproteome function and structure to anammox biofilm development
Kurth et al. Siderophores as molecular tools in medical and environmental applications
Ohno et al. The effects of reactive nitrogen intermediates on gene expression in Mycobacterium tuberculosis
Povolotsky et al. ‘Life-style’control networks in Escherichia coli: signaling by the second messenger c-di-GMP
Aubry et al. Mycobacterium tuberculosis DNA gyrase: interaction with quinolones and correlation with antimycobacterial drug activity
Li et al. Vancomycin resistance in Enterococcus and Staphylococcus aureus
MX2009010800A (es) Composiciones inmunogenicas que comprenden polipeptidos de mycobacterium tuberculosis y fusiones de los mismos.
MX2007008924A (es) Compuestos quimicos.
Stuart et al. Genomic island genes in a coastal marine Synechococcus strain confer enhanced tolerance to copper and oxidative stress
MX342764B (es) Composiciones y metodos para la distribucion selectiva de moleculas de oligonucleotidos a tipos especificos de neuronas.
TW200634003A (en) Chemical compounds
BRPI0710944B8 (pt) cultura biologicamente pura, e, composição e método para reduzir cólica infantil
ATE482194T1 (de) Indolonderivate, verfahren zu deren herstellung und deren anwendungen
PH12013502192A1 (en) Antibodies against human angiopoietin 2
WO2007109260A3 (en) Silicone elastomer gels
WO2007044413A3 (en) Wwox gene, vectors containing the same, and uses in treatment of cancer
MY148258A (en) Phenylamino-benzoxazole substituted carboxylic acids, method for their production and use thereof as medicaments
WO2008096012A3 (en) Multimeric conjugate
Hendrickson et al. Insights into dynamic polymicrobial synergy revealed by time-coursed RNA-Seq
MX367131B (es) Sales de xantilio 3,6-disustituidas.
Rodriguez et al. Metallobiology of tuberculosis
UA91541C2 (ru) Бактерицидные макроциклы v, которые содержат амидные группы
MY177984A (en) Aptamer for chymase, and use thereof
Fang et al. Discrimination and integration of stress signals by pathogenic bacteria
DK2257526T3 (da) Spiro(5,5)undecan-derivater